Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.

The American Journal of Cardiology
Aslan T Turer, Joseph A Hill

Abstract

Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion.

Associated Clinical Trials

References

Nov 1, 1992·Circulation Research·P KaplanW Flameng
Sep 16, 1991·Biochemical and Biophysical Research Communications·J M BondJ J Lemasters
Oct 1, 1990·Circulation Research·P G AndersonS B Digerness
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Mar 1, 1990·The Annals of Thoracic Surgery·G S WeinsteinD H Tyras
Jun 1, 1986·The Annals of Thoracic Surgery·A V GuffinJ A Kaplan
Nov 1, 1985·The Journal of Clinical Investigation·E Braunwald, R A Kloner
Dec 1, 1974·The Journal of Clinical Investigation·R A KlonerR B Jennings
Aug 11, 1995·The Journal of Biological Chemistry·Y Xia, J L Zweier
Jul 17, 1998·Trends in Pharmacological Sciences·P FerdinandyG F Baxter
Sep 6, 2000·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·A R AssaliO R Rosales
Oct 4, 2000·The Annals of Thoracic Surgery·S M WemanU S Salminen
May 4, 2001·Perfusion·A FabbriG Nardon
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S K Shernan, C D Collard
Oct 5, 2001·Journal of the American College of Cardiology·K KlatteUNKNOWN GUARDIAN Investigators (The GUARD during Ischemia Against Necrosis)
Apr 17, 2002·Journal of Cardiothoracic and Vascular Anesthesia·Mary P FillingerMark P Yeager
Mar 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Laura CalvilloMichael Brines
Jun 21, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Katare Gopalrao RajeshHironori Maeda

❮ Previous
Next ❯

Citations

Dec 12, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Puja GulatiNirmal Singh
Nov 10, 2010·Journal of Cardiovascular Translational Research·Steven J KattmanBlake D Anson
Mar 30, 2012·Journal of Physiology and Biochemistry·Bijun ZhaoDinghua Yi
Nov 5, 2013·European Journal of Pharmacology·Yahor TratsiakovichJohn Pernow
May 18, 2013·Experimental & Molecular Medicine·Young-Bin OhByung-Hyun Park
May 28, 2013·Nature Medicine·Edward T ChouchaniMichael P Murphy
Nov 15, 2011·Clinical and Experimental Pharmacology & Physiology·Mei ZhaoWei-Jin Zang
Oct 5, 2013·The Journal of Clinical Investigation·Hideshi OkadaRobert S Ross
Mar 1, 2012·Seminars in Cardiothoracic and Vascular Anesthesia·Anja FrankTobias Eckle
Jun 20, 2013·Cardiovascular Diabetology·Hong LiChuanshi Xiao
May 29, 2012·Molecular Medicine·Eli C Lewis
Jun 15, 2013·Oxidative Medicine and Cellular Longevity·Sverre E AuneMark G Angelos
Oct 3, 2014·BioMed Research International·Andreas HabertheuerDominik Wiedemann
Jan 1, 2014·Multimedia Manual of Cardiothoracic Surgery : MMCTS·Luca BottaLuigi Martinelli
Feb 13, 2016·Brain, Behavior, and Immunity·Iris B HovensRegien G Schoemaker
Jul 24, 2015·Expert Review of Cardiovascular Therapy·Andrew BinderIon S Jovin
Jan 9, 2016·Expert Opinion on Pharmacotherapy·Eirini PantaziJoan Roselló-Catafau
Feb 11, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Miaomiao JiangZheng Li
Feb 5, 2015·Cell Metabolism·Zhao V Wang, Joseph A Hill
Feb 5, 2016·Pediatric Cardiology·Nathaniel Sznycer-TaubJohn Charpie
Sep 29, 2015·Journal of Cardiothoracic and Vascular Anesthesia·Funda YildirimAlper Ozbakkaloglu
Mar 5, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Shiao DingJu Mei
Apr 7, 2012·The Journal of Surgical Research·Ning-Yan YangGuang-Yan Yu
Jul 13, 2011·Drug Discovery Today·Eline DejonckheereClaude Libert
Jul 15, 2015·The Journal of Physiology·Francisco AltamiranoJoseph A Hill
Jun 29, 2012·Journal of Thrombosis and Haemostasis : JTH·R CostaA R Rezaie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.